Neuropore Therapies, Inc.
Alzheimer’s Disease and Parkinson’s Disease are devastating neurological disorders that affect over 10 million in the US and Europe alone for which no cures are currently available. Neuropore Therapies Inc. (NPT) is a dynamic and innovative biopharmaceutical company dedicated to discovering new treatments for Alzheimer’s Disease, Parkinson’s Disease and related disorders. We are developing highly selective small molecule therapies that block the formation and accumulation of toxic protein aggregates in the brain and to promote the recovery of neuronal connections.
Our strong collaborations with academic centers in California allow us to rapidly discover new targets for intervention and to expand our pipeline of compounds for the treatment of neurodegenerative disorders. Our goal is to bring to the clinic more effective and selective treatments that will stop the progression of and/or revert the advancement of Alzheimer’s Disease, Parkinson’s Disease and linked neurological conditions.